Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Psychiatric Comorbidity and Multimorbidity in the EAGLES Trial: Descriptive Correlates and Associations With Neuropsychiatric Adverse Events, Treatment Adherence, and Smoking Cessation

Nicotine & Tobacco Research(2021)10.1093/ntr/ntab056Source: DataRank Database

Psychiatric Comorbidity and Multimorbidity in the EAGLES Trial: Descriptive Correlates and Associations With Neuropsychiatric Adverse Events, Treatment Adherence, and Smoking Cessation is a research paper published in Nicotine & Tobacco Research (2021). On theSindex it has a DataRank of 0.619. It has been cited 13 times, with 13 citing works in its 1-hop citation network.

N/A

0.619DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access13 citations · 13 citing works in its network

Download PDF

Cite:

Linked data & code

nct doi

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT01456936

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 1.14)OA: hybridTopics (65)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 64%Citation Network 36%

Base Score Contribution

0.396

From this paper's citation signal

Citation Network Contribution

0.223

From 12 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 13 citers.

Treatment adherence in a smoking cessation clinical trial for individuals with current or past major depressive disorder: Predictors and association with cessation
Addictive Behaviors20237 citations45 referencesContributes 0.046
Varenicline Over-The-Counter Trial on Efficacy and Safety
Nicotine & Tobacco Research20243 citations32 referencesContributes 0.043
Physical multimorbidity and quit outcomes in a publicly funded smoking cessation programme
Internal Medicine Journal20251 citations20 referencesContributes 0.035
Facilitators and barriers to smoking cessation: a qualitative study among health professionals in Germany
BMC Health Services Research20252 citations37 referencesContributes 0.030
The effect of a real-world intervention for smoking cessation in Adults with and without comorbid psychiatric and substance use disorders: A one-year follow-up study
Psychiatry Research20222 citations43 referencesContributes 0.026

Authors (8)

David Lawrence ORCID,Benjamin S McKenna,Natassia Gaznick,Phillip Saccone,Sarah Dubrava

Live enrichment

PubMed:33788933 PMC:PMC8521682 OpenAlex:https://openalex.org/W3143887521

National Institutes of Health

Grant: R01 DA037217

National Institutes of Health

Grant: R21 AA027634

National Institutes of Health

Grant: UO1 DA041731

NIDA NIH HHS

Grant: U01 DA041731

National Institutes of Health

Grant: 1R21AA027634-01A1

Exploring Potential Sex Differences In Neurobiological Mechanisms of Alcohol Sensitivity and Tolerance

National Institutes of Health

Grant: 5R01DA037217-03

Social Cognitive Theory and Nondaily Smoking, Escalation and Desistance

GlaxoSmithKline

Pfizer

Veterans Affairs Office of Academic Affiliations

FWCI

1.14

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

hybridLicense: public-domain

journalhttps://academic.oup.com/ntr/article-pdf/23/10/1646/40080130/ntab056.pdf

publisherhttps://academic.oup.com/ntr/article-pdf/23/10/1646/40080130/ntab056.pdf

publisherhttp://academic.oup.com/ntr/advance-article-pdf/doi/10.1093/ntr/ntab056/39463148/ntab056.pdf

publisherhttp://academic.oup.com/ntr/article-pdf/23/10/1646/40080130/ntab056.pdf

journalhttps://doi.org/10.1093/ntr/ntab056

Fields of Study

Smoking Behavior and CessationChronic Disease Management StrategiesSubstance Abuse Treatment and Outcomes03 medical and health sciences0302 clinical medicineBupropionHumansMaleMultimorbidityNicotinic AgonistsSmoking CessationTobacco Use Cessation DevicesTreatment Adherence and ComplianceVarenicline

MeSH Terms

VareniclineTreatment Adherence and ComplianceMultimorbidityHumansMaleSmoking CessationBupropionNicotinic AgonistsTobacco Use Cessation Devices

Keywords

MedicinePsychiatryComorbiditySmoking cessationVareniclineBupropionAbstinenceCohortOdds ratioInternal medicineNicotineMaleEpidemiologyClinical Trials and Supportive ActivitiesClinical Sciences150610CardiovascularSubstance MisuseClinical ResearchHealth Services and SystemsHealth SciencesBehavioral and Social ScienceTobaccoHumansNicotinic AgonistsCancerMarketingPublic healthTobacco Smoke and HealthPreventionMultimorbidityMental IllnessTobacco Use Cessation DevicesBrain DisordersTreatment Adherence and ComplianceMental HealthGood Health and Well Being6.1 PharmaceuticalsPublic Health and Health ServicesPatient SafetyDrug Abuse (NIDA only)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 16: 16. Peace & justiceSDG 0: Good health and well-being